Ceftriaxone Sodium 1 gm/vial
1 gm/vial
Injection
Ceftron-Vet® Injection is indicated for the treatment of the following infections when caused by susceptible organisms: Respiratory Tract Infection, Acute Bacterial Otitis Media, Skin & Skin Structure Infection, Urinary Tract Infection, Bone & Joint Infection, Bacterial Septicamia, Intra Abdominal Infection.
Dose
0.15 – 0.5
mL/kg
Frequency
q24h
Duration
3-7 days
Purpose
treatment
Ceftron-Vet 1® injection should be diluted with 10 ml WFI and injected at 12-24 hours interval. It can be administered either intramuscularly or intravenously. Dose: 15 to 50 mg/kg body weight or 1.5 -5 ml/10 kg body weight.
Dose
0.25 – 0.5
mL/kg
Frequency
q24h
Duration
3-7 days
Purpose
treatment
Ceftron-Vet 1® injection should be diluted with 10 ml WFI and injected at 12-24 hours interval. It can be administered either intramuscularly or intravenously. Dose: 25 to 50 mg/kg body weight or 0.25 -0.5 ml/10 kg body weight.
Dose
0.15 – 0.5
mL/kg
Frequency
q24h
Duration
3-7 days
Purpose
treatment
Ceftron-Vet 1® injection should be diluted with 10 ml WFI and injected at 12-24 hours interval. It can be administered either intramuscularly or intravenously. Dose: 15 to 50 mg/kg body weight or 7.5 -25 ml/50 kg body weight.
Dose
0.15 – 0.5
mL/kg
Frequency
q24h
Duration
3-7 days
Purpose
treatment
Ceftron-Vet 1® injection should be diluted with 10 ml WFI and injected at 12-24 hours interval. It can be administered either intramuscularly or intravenously. Dose: 15 to 50 mg/kg body weight or 1.5 -5 ml/10 kg body weight.
Dose
0.15 – 0.5
mL/kg
Frequency
q24h
Duration
3-7 days
Purpose
treatment
Ceftron-Vet 1® injection should be diluted with 10 ml WFI and injected at 12-24 hours interval. It can be administered either intramuscularly or intravenously. Dose: 15 to 50 mg/kg body weight or 1.5 -5 ml/10 kg body weight.
It should not be given to patients with a history of hypersensitivity to cephalosporin antibiotics. Transient elevations of BUN (Blood Urea Nitrogen) and serum creatinine have been observed. Alterations in prothrombin times have occurred rarely in animals treated with Ceftriaxone. Impaired vitamin K synthesis or low vitamin K stores (eg, chronic hepatic disease and malnutrition) may require monitoring of prothrombin time during Ceftriaxone treatment.